Global Cell and Gene Therapy (CGT) Logistic Market Growth (Status and Outlook) 2026-2032
The global Cell and Gene Therapy (CGT) Logistic market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
The market for cell and gene therapies (CGT) is poised for immense growth in the upcoming years, with a plethora of potential products progressing from early-stage clinical trials to commercialization and beyond. Accurate storage specifications and a limited timeframe for transportation are necessary for the shipment of numerous cell therapies that often require international delivery that will require customs clearance.
United States market for Cell and Gene Therapy (CGT) Logistic is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Cell and Gene Therapy (CGT) Logistic is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Cell and Gene Therapy (CGT) Logistic is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Cell and Gene Therapy (CGT) Logistic players cover Cencora, Inc?World Courier?, QuickStat, Associated Couriers, LLC, Central Pharma, POLAR EXPRES, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LPI (LP Information)' newest research report, the ?Cell and Gene Therapy (CGT) Logistic Industry Forecast? looks at past sales and reviews total world Cell and Gene Therapy (CGT) Logistic sales in 2025, providing a comprehensive analysis by region and market sector of projected Cell and Gene Therapy (CGT) Logistic sales for 2026 through 2032. With Cell and Gene Therapy (CGT) Logistic sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cell and Gene Therapy (CGT) Logistic industry.
This Insight Report provides a comprehensive analysis of the global Cell and Gene Therapy (CGT) Logistic landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Cell and Gene Therapy (CGT) Logistic portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Cell and Gene Therapy (CGT) Logistic market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cell and Gene Therapy (CGT) Logistic and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cell and Gene Therapy (CGT) Logistic.
This report presents a comprehensive overview, market shares, and growth opportunities of Cell and Gene Therapy (CGT) Logistic market by product type, application, key players and key regions and countries.
Segmentation by Type:
The market for cell and gene therapies (CGT) is poised for immense growth in the upcoming years, with a plethora of potential products progressing from early-stage clinical trials to commercialization and beyond. Accurate storage specifications and a limited timeframe for transportation are necessary for the shipment of numerous cell therapies that often require international delivery that will require customs clearance.
United States market for Cell and Gene Therapy (CGT) Logistic is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Cell and Gene Therapy (CGT) Logistic is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Cell and Gene Therapy (CGT) Logistic is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Cell and Gene Therapy (CGT) Logistic players cover Cencora, Inc?World Courier?, QuickStat, Associated Couriers, LLC, Central Pharma, POLAR EXPRES, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LPI (LP Information)' newest research report, the ?Cell and Gene Therapy (CGT) Logistic Industry Forecast? looks at past sales and reviews total world Cell and Gene Therapy (CGT) Logistic sales in 2025, providing a comprehensive analysis by region and market sector of projected Cell and Gene Therapy (CGT) Logistic sales for 2026 through 2032. With Cell and Gene Therapy (CGT) Logistic sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cell and Gene Therapy (CGT) Logistic industry.
This Insight Report provides a comprehensive analysis of the global Cell and Gene Therapy (CGT) Logistic landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Cell and Gene Therapy (CGT) Logistic portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Cell and Gene Therapy (CGT) Logistic market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cell and Gene Therapy (CGT) Logistic and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cell and Gene Therapy (CGT) Logistic.
This report presents a comprehensive overview, market shares, and growth opportunities of Cell and Gene Therapy (CGT) Logistic market by product type, application, key players and key regions and countries.
Segmentation by Type:
- National Transportation
- International Transportation
- Biotech and Pharmaceutical Companies
- Hospitals
- Research Organizations
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Cencora, Inc?World Courier?
- QuickStat
- Associated Couriers, LLC
- Central Pharma
- POLAR EXPRES
- Biocair
- time:matters
- Mercury Business Services
- Cardinal Health
- CRYOPDP
- Cryoport
- NMDP BioTherapies
- McKesson
- Excel Courier
- Almac
- BEAM Logistics
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Cell and Gene Therapy (CGT) Logistic Market Size (2021-2032)
2.1.2 Cell and Gene Therapy (CGT) Logistic Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Cell and Gene Therapy (CGT) Logistic by Country/Region (2021, 2025 & 2032)
2.2 Cell and Gene Therapy (CGT) Logistic Segment by Type
2.2.1 National Transportation
2.2.2 International Transportation
2.2.3 Cell and Gene Therapy (CGT) Logistic Market Size by Type
2.2.3.1 Cell and Gene Therapy (CGT) Logistic Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.3.2 Global Cell and Gene Therapy (CGT) Logistic Market Size Market Share by Type (2021-2026)
2.3 Cell and Gene Therapy (CGT) Logistic Segment by Application
2.3.1 Biotech and Pharmaceutical Companies
2.3.2 Hospitals
2.3.3 Research Organizations
2.3.4 Other
2.3.5 Cell and Gene Therapy (CGT) Logistic Market Size by Application
2.3.5.1 Cell and Gene Therapy (CGT) Logistic Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.5.2 Global Cell and Gene Therapy (CGT) Logistic Market Size Market Share by Application (2021-2026)
3 CELL AND GENE THERAPY (CGT) LOGISTIC MARKET SIZE BY PLAYER
3.1 Cell and Gene Therapy (CGT) Logistic Market Size Market Share by Player
3.1.1 Global Cell and Gene Therapy (CGT) Logistic Revenue by Player (2021-2026)
3.1.2 Global Cell and Gene Therapy (CGT) Logistic Revenue Market Share by Player (2021-2026)
3.2 Global Cell and Gene Therapy (CGT) Logistic Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 CELL AND GENE THERAPY (CGT) LOGISTIC BY REGION
4.1 Cell and Gene Therapy (CGT) Logistic Market Size by Region (2021-2026)
4.2 Global Cell and Gene Therapy (CGT) Logistic Annual Revenue by Country/Region (2021-2026)
4.3 Americas Cell and Gene Therapy (CGT) Logistic Market Size Growth (2021-2026)
4.4 APAC Cell and Gene Therapy (CGT) Logistic Market Size Growth (2021-2026)
4.5 Europe Cell and Gene Therapy (CGT) Logistic Market Size Growth (2021-2026)
4.6 Middle East & Africa Cell and Gene Therapy (CGT) Logistic Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Cell and Gene Therapy (CGT) Logistic Market Size by Country (2021-2026)
5.2 Americas Cell and Gene Therapy (CGT) Logistic Market Size by Type (2021-2026)
5.3 Americas Cell and Gene Therapy (CGT) Logistic Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Cell and Gene Therapy (CGT) Logistic Market Size by Region (2021-2026)
6.2 APAC Cell and Gene Therapy (CGT) Logistic Market Size by Type (2021-2026)
6.3 APAC Cell and Gene Therapy (CGT) Logistic Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Cell and Gene Therapy (CGT) Logistic Market Size by Country (2021-2026)
7.2 Europe Cell and Gene Therapy (CGT) Logistic Market Size by Type (2021-2026)
7.3 Europe Cell and Gene Therapy (CGT) Logistic Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Cell and Gene Therapy (CGT) Logistic by Region (2021-2026)
8.2 Middle East & Africa Cell and Gene Therapy (CGT) Logistic Market Size by Type (2021-2026)
8.3 Middle East & Africa Cell and Gene Therapy (CGT) Logistic Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL CELL AND GENE THERAPY (CGT) LOGISTIC MARKET FORECAST
10.1 Global Cell and Gene Therapy (CGT) Logistic Forecast by Region (2027-2032)
10.1.1 Global Cell and Gene Therapy (CGT) Logistic Forecast by Region (2027-2032)
10.1.2 Americas Cell and Gene Therapy (CGT) Logistic Forecast
10.1.3 APAC Cell and Gene Therapy (CGT) Logistic Forecast
10.1.4 Europe Cell and Gene Therapy (CGT) Logistic Forecast
10.1.5 Middle East & Africa Cell and Gene Therapy (CGT) Logistic Forecast
10.2 Americas Cell and Gene Therapy (CGT) Logistic Forecast by Country (2027-2032)
10.2.1 United States Market Cell and Gene Therapy (CGT) Logistic Forecast
10.2.2 Canada Market Cell and Gene Therapy (CGT) Logistic Forecast
10.2.3 Mexico Market Cell and Gene Therapy (CGT) Logistic Forecast
10.2.4 Brazil Market Cell and Gene Therapy (CGT) Logistic Forecast
10.3 APAC Cell and Gene Therapy (CGT) Logistic Forecast by Region (2027-2032)
10.3.1 China Cell and Gene Therapy (CGT) Logistic Market Forecast
10.3.2 Japan Market Cell and Gene Therapy (CGT) Logistic Forecast
10.3.3 Korea Market Cell and Gene Therapy (CGT) Logistic Forecast
10.3.4 Southeast Asia Market Cell and Gene Therapy (CGT) Logistic Forecast
10.3.5 India Market Cell and Gene Therapy (CGT) Logistic Forecast
10.3.6 Australia Market Cell and Gene Therapy (CGT) Logistic Forecast
10.4 Europe Cell and Gene Therapy (CGT) Logistic Forecast by Country (2027-2032)
10.4.1 Germany Market Cell and Gene Therapy (CGT) Logistic Forecast
10.4.2 France Market Cell and Gene Therapy (CGT) Logistic Forecast
10.4.3 UK Market Cell and Gene Therapy (CGT) Logistic Forecast
10.4.4 Italy Market Cell and Gene Therapy (CGT) Logistic Forecast
10.4.5 Russia Market Cell and Gene Therapy (CGT) Logistic Forecast
10.5 Middle East & Africa Cell and Gene Therapy (CGT) Logistic Forecast by Region (2027-2032)
10.5.1 Egypt Market Cell and Gene Therapy (CGT) Logistic Forecast
10.5.2 South Africa Market Cell and Gene Therapy (CGT) Logistic Forecast
10.5.3 Israel Market Cell and Gene Therapy (CGT) Logistic Forecast
10.5.4 Turkey Market Cell and Gene Therapy (CGT) Logistic Forecast
10.6 Global Cell and Gene Therapy (CGT) Logistic Forecast by Type (2027-2032)
10.7 Global Cell and Gene Therapy (CGT) Logistic Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Cell and Gene Therapy (CGT) Logistic Forecast
11 KEY PLAYERS ANALYSIS
11.1 Cencora, Inc(World Courier)
11.1.1 Cencora, Inc(World Courier) Company Information
11.1.2 Cencora, Inc(World Courier) Cell and Gene Therapy (CGT) Logistic Product Offered
11.1.3 Cencora, Inc(World Courier) Cell and Gene Therapy (CGT) Logistic Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Cencora, Inc(World Courier) Main Business Overview
11.1.5 Cencora, Inc(World Courier) Latest Developments
11.2 QuickStat
11.2.1 QuickStat Company Information
11.2.2 QuickStat Cell and Gene Therapy (CGT) Logistic Product Offered
11.2.3 QuickStat Cell and Gene Therapy (CGT) Logistic Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 QuickStat Main Business Overview
11.2.5 QuickStat Latest Developments
11.3 Associated Couriers, LLC
11.3.1 Associated Couriers, LLC Company Information
11.3.2 Associated Couriers, LLC Cell and Gene Therapy (CGT) Logistic Product Offered
11.3.3 Associated Couriers, LLC Cell and Gene Therapy (CGT) Logistic Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Associated Couriers, LLC Main Business Overview
11.3.5 Associated Couriers, LLC Latest Developments
11.4 Central Pharma
11.4.1 Central Pharma Company Information
11.4.2 Central Pharma Cell and Gene Therapy (CGT) Logistic Product Offered
11.4.3 Central Pharma Cell and Gene Therapy (CGT) Logistic Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Central Pharma Main Business Overview
11.4.5 Central Pharma Latest Developments
11.5 POLAR EXPRES
11.5.1 POLAR EXPRES Company Information
11.5.2 POLAR EXPRES Cell and Gene Therapy (CGT) Logistic Product Offered
11.5.3 POLAR EXPRES Cell and Gene Therapy (CGT) Logistic Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 POLAR EXPRES Main Business Overview
11.5.5 POLAR EXPRES Latest Developments
11.6 Biocair
11.6.1 Biocair Company Information
11.6.2 Biocair Cell and Gene Therapy (CGT) Logistic Product Offered
11.6.3 Biocair Cell and Gene Therapy (CGT) Logistic Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Biocair Main Business Overview
11.6.5 Biocair Latest Developments
11.7 time:matters
11.7.1 time:matters Company Information
11.7.2 time:matters Cell and Gene Therapy (CGT) Logistic Product Offered
11.7.3 time:matters Cell and Gene Therapy (CGT) Logistic Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 time:matters Main Business Overview
11.7.5 time:matters Latest Developments
11.8 Mercury Business Services
11.8.1 Mercury Business Services Company Information
11.8.2 Mercury Business Services Cell and Gene Therapy (CGT) Logistic Product Offered
11.8.3 Mercury Business Services Cell and Gene Therapy (CGT) Logistic Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Mercury Business Services Main Business Overview
11.8.5 Mercury Business Services Latest Developments
11.9 Cardinal Health
11.9.1 Cardinal Health Company Information
11.9.2 Cardinal Health Cell and Gene Therapy (CGT) Logistic Product Offered
11.9.3 Cardinal Health Cell and Gene Therapy (CGT) Logistic Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Cardinal Health Main Business Overview
11.9.5 Cardinal Health Latest Developments
11.10 CRYOPDP
11.10.1 CRYOPDP Company Information
11.10.2 CRYOPDP Cell and Gene Therapy (CGT) Logistic Product Offered
11.10.3 CRYOPDP Cell and Gene Therapy (CGT) Logistic Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 CRYOPDP Main Business Overview
11.10.5 CRYOPDP Latest Developments
11.11 Cryoport
11.11.1 Cryoport Company Information
11.11.2 Cryoport Cell and Gene Therapy (CGT) Logistic Product Offered
11.11.3 Cryoport Cell and Gene Therapy (CGT) Logistic Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Cryoport Main Business Overview
11.11.5 Cryoport Latest Developments
11.12 NMDP BioTherapies
11.12.1 NMDP BioTherapies Company Information
11.12.2 NMDP BioTherapies Cell and Gene Therapy (CGT) Logistic Product Offered
11.12.3 NMDP BioTherapies Cell and Gene Therapy (CGT) Logistic Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 NMDP BioTherapies Main Business Overview
11.12.5 NMDP BioTherapies Latest Developments
11.13 McKesson
11.13.1 McKesson Company Information
11.13.2 McKesson Cell and Gene Therapy (CGT) Logistic Product Offered
11.13.3 McKesson Cell and Gene Therapy (CGT) Logistic Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 McKesson Main Business Overview
11.13.5 McKesson Latest Developments
11.14 Excel Courier
11.14.1 Excel Courier Company Information
11.14.2 Excel Courier Cell and Gene Therapy (CGT) Logistic Product Offered
11.14.3 Excel Courier Cell and Gene Therapy (CGT) Logistic Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Excel Courier Main Business Overview
11.14.5 Excel Courier Latest Developments
11.15 Almac
11.15.1 Almac Company Information
11.15.2 Almac Cell and Gene Therapy (CGT) Logistic Product Offered
11.15.3 Almac Cell and Gene Therapy (CGT) Logistic Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 Almac Main Business Overview
11.15.5 Almac Latest Developments
11.16 BEAM Logistics
11.16.1 BEAM Logistics Company Information
11.16.2 BEAM Logistics Cell and Gene Therapy (CGT) Logistic Product Offered
11.16.3 BEAM Logistics Cell and Gene Therapy (CGT) Logistic Revenue, Gross Margin and Market Share (2021-2026)
11.16.4 BEAM Logistics Main Business Overview
11.16.5 BEAM Logistics Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Cell and Gene Therapy (CGT) Logistic Market Size (2021-2032)
2.1.2 Cell and Gene Therapy (CGT) Logistic Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Cell and Gene Therapy (CGT) Logistic by Country/Region (2021, 2025 & 2032)
2.2 Cell and Gene Therapy (CGT) Logistic Segment by Type
2.2.1 National Transportation
2.2.2 International Transportation
2.2.3 Cell and Gene Therapy (CGT) Logistic Market Size by Type
2.2.3.1 Cell and Gene Therapy (CGT) Logistic Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.3.2 Global Cell and Gene Therapy (CGT) Logistic Market Size Market Share by Type (2021-2026)
2.3 Cell and Gene Therapy (CGT) Logistic Segment by Application
2.3.1 Biotech and Pharmaceutical Companies
2.3.2 Hospitals
2.3.3 Research Organizations
2.3.4 Other
2.3.5 Cell and Gene Therapy (CGT) Logistic Market Size by Application
2.3.5.1 Cell and Gene Therapy (CGT) Logistic Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.5.2 Global Cell and Gene Therapy (CGT) Logistic Market Size Market Share by Application (2021-2026)
3 CELL AND GENE THERAPY (CGT) LOGISTIC MARKET SIZE BY PLAYER
3.1 Cell and Gene Therapy (CGT) Logistic Market Size Market Share by Player
3.1.1 Global Cell and Gene Therapy (CGT) Logistic Revenue by Player (2021-2026)
3.1.2 Global Cell and Gene Therapy (CGT) Logistic Revenue Market Share by Player (2021-2026)
3.2 Global Cell and Gene Therapy (CGT) Logistic Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 CELL AND GENE THERAPY (CGT) LOGISTIC BY REGION
4.1 Cell and Gene Therapy (CGT) Logistic Market Size by Region (2021-2026)
4.2 Global Cell and Gene Therapy (CGT) Logistic Annual Revenue by Country/Region (2021-2026)
4.3 Americas Cell and Gene Therapy (CGT) Logistic Market Size Growth (2021-2026)
4.4 APAC Cell and Gene Therapy (CGT) Logistic Market Size Growth (2021-2026)
4.5 Europe Cell and Gene Therapy (CGT) Logistic Market Size Growth (2021-2026)
4.6 Middle East & Africa Cell and Gene Therapy (CGT) Logistic Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Cell and Gene Therapy (CGT) Logistic Market Size by Country (2021-2026)
5.2 Americas Cell and Gene Therapy (CGT) Logistic Market Size by Type (2021-2026)
5.3 Americas Cell and Gene Therapy (CGT) Logistic Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Cell and Gene Therapy (CGT) Logistic Market Size by Region (2021-2026)
6.2 APAC Cell and Gene Therapy (CGT) Logistic Market Size by Type (2021-2026)
6.3 APAC Cell and Gene Therapy (CGT) Logistic Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Cell and Gene Therapy (CGT) Logistic Market Size by Country (2021-2026)
7.2 Europe Cell and Gene Therapy (CGT) Logistic Market Size by Type (2021-2026)
7.3 Europe Cell and Gene Therapy (CGT) Logistic Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Cell and Gene Therapy (CGT) Logistic by Region (2021-2026)
8.2 Middle East & Africa Cell and Gene Therapy (CGT) Logistic Market Size by Type (2021-2026)
8.3 Middle East & Africa Cell and Gene Therapy (CGT) Logistic Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL CELL AND GENE THERAPY (CGT) LOGISTIC MARKET FORECAST
10.1 Global Cell and Gene Therapy (CGT) Logistic Forecast by Region (2027-2032)
10.1.1 Global Cell and Gene Therapy (CGT) Logistic Forecast by Region (2027-2032)
10.1.2 Americas Cell and Gene Therapy (CGT) Logistic Forecast
10.1.3 APAC Cell and Gene Therapy (CGT) Logistic Forecast
10.1.4 Europe Cell and Gene Therapy (CGT) Logistic Forecast
10.1.5 Middle East & Africa Cell and Gene Therapy (CGT) Logistic Forecast
10.2 Americas Cell and Gene Therapy (CGT) Logistic Forecast by Country (2027-2032)
10.2.1 United States Market Cell and Gene Therapy (CGT) Logistic Forecast
10.2.2 Canada Market Cell and Gene Therapy (CGT) Logistic Forecast
10.2.3 Mexico Market Cell and Gene Therapy (CGT) Logistic Forecast
10.2.4 Brazil Market Cell and Gene Therapy (CGT) Logistic Forecast
10.3 APAC Cell and Gene Therapy (CGT) Logistic Forecast by Region (2027-2032)
10.3.1 China Cell and Gene Therapy (CGT) Logistic Market Forecast
10.3.2 Japan Market Cell and Gene Therapy (CGT) Logistic Forecast
10.3.3 Korea Market Cell and Gene Therapy (CGT) Logistic Forecast
10.3.4 Southeast Asia Market Cell and Gene Therapy (CGT) Logistic Forecast
10.3.5 India Market Cell and Gene Therapy (CGT) Logistic Forecast
10.3.6 Australia Market Cell and Gene Therapy (CGT) Logistic Forecast
10.4 Europe Cell and Gene Therapy (CGT) Logistic Forecast by Country (2027-2032)
10.4.1 Germany Market Cell and Gene Therapy (CGT) Logistic Forecast
10.4.2 France Market Cell and Gene Therapy (CGT) Logistic Forecast
10.4.3 UK Market Cell and Gene Therapy (CGT) Logistic Forecast
10.4.4 Italy Market Cell and Gene Therapy (CGT) Logistic Forecast
10.4.5 Russia Market Cell and Gene Therapy (CGT) Logistic Forecast
10.5 Middle East & Africa Cell and Gene Therapy (CGT) Logistic Forecast by Region (2027-2032)
10.5.1 Egypt Market Cell and Gene Therapy (CGT) Logistic Forecast
10.5.2 South Africa Market Cell and Gene Therapy (CGT) Logistic Forecast
10.5.3 Israel Market Cell and Gene Therapy (CGT) Logistic Forecast
10.5.4 Turkey Market Cell and Gene Therapy (CGT) Logistic Forecast
10.6 Global Cell and Gene Therapy (CGT) Logistic Forecast by Type (2027-2032)
10.7 Global Cell and Gene Therapy (CGT) Logistic Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Cell and Gene Therapy (CGT) Logistic Forecast
11 KEY PLAYERS ANALYSIS
11.1 Cencora, Inc(World Courier)
11.1.1 Cencora, Inc(World Courier) Company Information
11.1.2 Cencora, Inc(World Courier) Cell and Gene Therapy (CGT) Logistic Product Offered
11.1.3 Cencora, Inc(World Courier) Cell and Gene Therapy (CGT) Logistic Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Cencora, Inc(World Courier) Main Business Overview
11.1.5 Cencora, Inc(World Courier) Latest Developments
11.2 QuickStat
11.2.1 QuickStat Company Information
11.2.2 QuickStat Cell and Gene Therapy (CGT) Logistic Product Offered
11.2.3 QuickStat Cell and Gene Therapy (CGT) Logistic Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 QuickStat Main Business Overview
11.2.5 QuickStat Latest Developments
11.3 Associated Couriers, LLC
11.3.1 Associated Couriers, LLC Company Information
11.3.2 Associated Couriers, LLC Cell and Gene Therapy (CGT) Logistic Product Offered
11.3.3 Associated Couriers, LLC Cell and Gene Therapy (CGT) Logistic Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Associated Couriers, LLC Main Business Overview
11.3.5 Associated Couriers, LLC Latest Developments
11.4 Central Pharma
11.4.1 Central Pharma Company Information
11.4.2 Central Pharma Cell and Gene Therapy (CGT) Logistic Product Offered
11.4.3 Central Pharma Cell and Gene Therapy (CGT) Logistic Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Central Pharma Main Business Overview
11.4.5 Central Pharma Latest Developments
11.5 POLAR EXPRES
11.5.1 POLAR EXPRES Company Information
11.5.2 POLAR EXPRES Cell and Gene Therapy (CGT) Logistic Product Offered
11.5.3 POLAR EXPRES Cell and Gene Therapy (CGT) Logistic Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 POLAR EXPRES Main Business Overview
11.5.5 POLAR EXPRES Latest Developments
11.6 Biocair
11.6.1 Biocair Company Information
11.6.2 Biocair Cell and Gene Therapy (CGT) Logistic Product Offered
11.6.3 Biocair Cell and Gene Therapy (CGT) Logistic Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Biocair Main Business Overview
11.6.5 Biocair Latest Developments
11.7 time:matters
11.7.1 time:matters Company Information
11.7.2 time:matters Cell and Gene Therapy (CGT) Logistic Product Offered
11.7.3 time:matters Cell and Gene Therapy (CGT) Logistic Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 time:matters Main Business Overview
11.7.5 time:matters Latest Developments
11.8 Mercury Business Services
11.8.1 Mercury Business Services Company Information
11.8.2 Mercury Business Services Cell and Gene Therapy (CGT) Logistic Product Offered
11.8.3 Mercury Business Services Cell and Gene Therapy (CGT) Logistic Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Mercury Business Services Main Business Overview
11.8.5 Mercury Business Services Latest Developments
11.9 Cardinal Health
11.9.1 Cardinal Health Company Information
11.9.2 Cardinal Health Cell and Gene Therapy (CGT) Logistic Product Offered
11.9.3 Cardinal Health Cell and Gene Therapy (CGT) Logistic Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Cardinal Health Main Business Overview
11.9.5 Cardinal Health Latest Developments
11.10 CRYOPDP
11.10.1 CRYOPDP Company Information
11.10.2 CRYOPDP Cell and Gene Therapy (CGT) Logistic Product Offered
11.10.3 CRYOPDP Cell and Gene Therapy (CGT) Logistic Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 CRYOPDP Main Business Overview
11.10.5 CRYOPDP Latest Developments
11.11 Cryoport
11.11.1 Cryoport Company Information
11.11.2 Cryoport Cell and Gene Therapy (CGT) Logistic Product Offered
11.11.3 Cryoport Cell and Gene Therapy (CGT) Logistic Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Cryoport Main Business Overview
11.11.5 Cryoport Latest Developments
11.12 NMDP BioTherapies
11.12.1 NMDP BioTherapies Company Information
11.12.2 NMDP BioTherapies Cell and Gene Therapy (CGT) Logistic Product Offered
11.12.3 NMDP BioTherapies Cell and Gene Therapy (CGT) Logistic Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 NMDP BioTherapies Main Business Overview
11.12.5 NMDP BioTherapies Latest Developments
11.13 McKesson
11.13.1 McKesson Company Information
11.13.2 McKesson Cell and Gene Therapy (CGT) Logistic Product Offered
11.13.3 McKesson Cell and Gene Therapy (CGT) Logistic Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 McKesson Main Business Overview
11.13.5 McKesson Latest Developments
11.14 Excel Courier
11.14.1 Excel Courier Company Information
11.14.2 Excel Courier Cell and Gene Therapy (CGT) Logistic Product Offered
11.14.3 Excel Courier Cell and Gene Therapy (CGT) Logistic Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Excel Courier Main Business Overview
11.14.5 Excel Courier Latest Developments
11.15 Almac
11.15.1 Almac Company Information
11.15.2 Almac Cell and Gene Therapy (CGT) Logistic Product Offered
11.15.3 Almac Cell and Gene Therapy (CGT) Logistic Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 Almac Main Business Overview
11.15.5 Almac Latest Developments
11.16 BEAM Logistics
11.16.1 BEAM Logistics Company Information
11.16.2 BEAM Logistics Cell and Gene Therapy (CGT) Logistic Product Offered
11.16.3 BEAM Logistics Cell and Gene Therapy (CGT) Logistic Revenue, Gross Margin and Market Share (2021-2026)
11.16.4 BEAM Logistics Main Business Overview
11.16.5 BEAM Logistics Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Cell and Gene Therapy (CGT) Logistic Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Cell and Gene Therapy (CGT) Logistic Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of National Transportation
Table 4. Major Players of International Transportation
Table 5. Cell and Gene Therapy (CGT) Logistic Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global Cell and Gene Therapy (CGT) Logistic Market Size by Type (2021-2026) & ($ millions)
Table 7. Global Cell and Gene Therapy (CGT) Logistic Market Size Market Share by Type (2021-2026)
Table 8. Cell and Gene Therapy (CGT) Logistic Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 9. Global Cell and Gene Therapy (CGT) Logistic Market Size by Application (2021-2026) & ($ millions)
Table 10. Global Cell and Gene Therapy (CGT) Logistic Market Size Market Share by Application (2021-2026)
Table 11. Global Cell and Gene Therapy (CGT) Logistic Revenue by Player (2021-2026) & ($ millions)
Table 12. Global Cell and Gene Therapy (CGT) Logistic Revenue Market Share by Player (2021-2026)
Table 13. Cell and Gene Therapy (CGT) Logistic Key Players Head office and Products Offered
Table 14. Cell and Gene Therapy (CGT) Logistic Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Cell and Gene Therapy (CGT) Logistic Market Size by Region (2021-2026) & ($ millions)
Table 18. Global Cell and Gene Therapy (CGT) Logistic Market Size Market Share by Region (2021-2026)
Table 19. Global Cell and Gene Therapy (CGT) Logistic Revenue by Country/Region (2021-2026) & ($ millions)
Table 20. Global Cell and Gene Therapy (CGT) Logistic Revenue Market Share by Country/Region (2021-2026)
Table 21. Americas Cell and Gene Therapy (CGT) Logistic Market Size by Country (2021-2026) & ($ millions)
Table 22. Americas Cell and Gene Therapy (CGT) Logistic Market Size Market Share by Country (2021-2026)
Table 23. Americas Cell and Gene Therapy (CGT) Logistic Market Size by Type (2021-2026) & ($ millions)
Table 24. Americas Cell and Gene Therapy (CGT) Logistic Market Size Market Share by Type (2021-2026)
Table 25. Americas Cell and Gene Therapy (CGT) Logistic Market Size by Application (2021-2026) & ($ millions)
Table 26. Americas Cell and Gene Therapy (CGT) Logistic Market Size Market Share by Application (2021-2026)
Table 27. APAC Cell and Gene Therapy (CGT) Logistic Market Size by Region (2021-2026) & ($ millions)
Table 28. APAC Cell and Gene Therapy (CGT) Logistic Market Size Market Share by Region (2021-2026)
Table 29. APAC Cell and Gene Therapy (CGT) Logistic Market Size by Type (2021-2026) & ($ millions)
Table 30. APAC Cell and Gene Therapy (CGT) Logistic Market Size by Application (2021-2026) & ($ millions)
Table 31. Europe Cell and Gene Therapy (CGT) Logistic Market Size by Country (2021-2026) & ($ millions)
Table 32. Europe Cell and Gene Therapy (CGT) Logistic Market Size Market Share by Country (2021-2026)
Table 33. Europe Cell and Gene Therapy (CGT) Logistic Market Size by Type (2021-2026) & ($ millions)
Table 34. Europe Cell and Gene Therapy (CGT) Logistic Market Size by Application (2021-2026) & ($ millions)
Table 35. Middle East & Africa Cell and Gene Therapy (CGT) Logistic Market Size by Region (2021-2026) & ($ millions)
Table 36. Middle East & Africa Cell and Gene Therapy (CGT) Logistic Market Size by Type (2021-2026) & ($ millions)
Table 37. Middle East & Africa Cell and Gene Therapy (CGT) Logistic Market Size by Application (2021-2026) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Cell and Gene Therapy (CGT) Logistic
Table 39. Key Market Challenges & Risks of Cell and Gene Therapy (CGT) Logistic
Table 40. Key Industry Trends of Cell and Gene Therapy (CGT) Logistic
Table 41. Global Cell and Gene Therapy (CGT) Logistic Market Size Forecast by Region (2027-2032) & ($ millions)
Table 42. Global Cell and Gene Therapy (CGT) Logistic Market Size Market Share Forecast by Region (2027-2032)
Table 43. Global Cell and Gene Therapy (CGT) Logistic Market Size Forecast by Type (2027-2032) & ($ millions)
Table 44. Global Cell and Gene Therapy (CGT) Logistic Market Size Forecast by Application (2027-2032) & ($ millions)
Table 45. Cencora, Inc?World Courier? Details, Company Type, Cell and Gene Therapy (CGT) Logistic Area Served and Its Competitors
Table 46. Cencora, Inc?World Courier? Cell and Gene Therapy (CGT) Logistic Product Offered
Table 47. Cencora, Inc?World Courier? Cell and Gene Therapy (CGT) Logistic Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 48. Cencora, Inc?World Courier? Main Business
Table 49. Cencora, Inc?World Courier? Latest Developments
Table 50. QuickStat Details, Company Type, Cell and Gene Therapy (CGT) Logistic Area Served and Its Competitors
Table 51. QuickStat Cell and Gene Therapy (CGT) Logistic Product Offered
Table 52. QuickStat Cell and Gene Therapy (CGT) Logistic Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 53. QuickStat Main Business
Table 54. QuickStat Latest Developments
Table 55. Associated Couriers, LLC Details, Company Type, Cell and Gene Therapy (CGT) Logistic Area Served and Its Competitors
Table 56. Associated Couriers, LLC Cell and Gene Therapy (CGT) Logistic Product Offered
Table 57. Associated Couriers, LLC Cell and Gene Therapy (CGT) Logistic Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 58. Associated Couriers, LLC Main Business
Table 59. Associated Couriers, LLC Latest Developments
Table 60. Central Pharma Details, Company Type, Cell and Gene Therapy (CGT) Logistic Area Served and Its Competitors
Table 61. Central Pharma Cell and Gene Therapy (CGT) Logistic Product Offered
Table 62. Central Pharma Cell and Gene Therapy (CGT) Logistic Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 63. Central Pharma Main Business
Table 64. Central Pharma Latest Developments
Table 65. POLAR EXPRES Details, Company Type, Cell and Gene Therapy (CGT) Logistic Area Served and Its Competitors
Table 66. POLAR EXPRES Cell and Gene Therapy (CGT) Logistic Product Offered
Table 67. POLAR EXPRES Cell and Gene Therapy (CGT) Logistic Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 68. POLAR EXPRES Main Business
Table 69. POLAR EXPRES Latest Developments
Table 70. Biocair Details, Company Type, Cell and Gene Therapy (CGT) Logistic Area Served and Its Competitors
Table 71. Biocair Cell and Gene Therapy (CGT) Logistic Product Offered
Table 72. Biocair Cell and Gene Therapy (CGT) Logistic Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 73. Biocair Main Business
Table 74. Biocair Latest Developments
Table 75. time:matters Details, Company Type, Cell and Gene Therapy (CGT) Logistic Area Served and Its Competitors
Table 76. time:matters Cell and Gene Therapy (CGT) Logistic Product Offered
Table 77. time:matters Cell and Gene Therapy (CGT) Logistic Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 78. time:matters Main Business
Table 79. time:matters Latest Developments
Table 80. Mercury Business Services Details, Company Type, Cell and Gene Therapy (CGT) Logistic Area Served and Its Competitors
Table 81. Mercury Business Services Cell and Gene Therapy (CGT) Logistic Product Offered
Table 82. Mercury Business Services Cell and Gene Therapy (CGT) Logistic Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 83. Mercury Business Services Main Business
Table 84. Mercury Business Services Latest Developments
Table 85. Cardinal Health Details, Company Type, Cell and Gene Therapy (CGT) Logistic Area Served and Its Competitors
Table 86. Cardinal Health Cell and Gene Therapy (CGT) Logistic Product Offered
Table 87. Cardinal Health Cell and Gene Therapy (CGT) Logistic Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 88. Cardinal Health Main Business
Table 89. Cardinal Health Latest Developments
Table 90. CRYOPDP Details, Company Type, Cell and Gene Therapy (CGT) Logistic Area Served and Its Competitors
Table 91. CRYOPDP Cell and Gene Therapy (CGT) Logistic Product Offered
Table 92. CRYOPDP Cell and Gene Therapy (CGT) Logistic Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 93. CRYOPDP Main Business
Table 94. CRYOPDP Latest Developments
Table 95. Cryoport Details, Company Type, Cell and Gene Therapy (CGT) Logistic Area Served and Its Competitors
Table 96. Cryoport Cell and Gene Therapy (CGT) Logistic Product Offered
Table 97. Cryoport Cell and Gene Therapy (CGT) Logistic Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 98. Cryoport Main Business
Table 99. Cryoport Latest Developments
Table 100. NMDP BioTherapies Details, Company Type, Cell and Gene Therapy (CGT) Logistic Area Served and Its Competitors
Table 101. NMDP BioTherapies Cell and Gene Therapy (CGT) Logistic Product Offered
Table 102. NMDP BioTherapies Cell and Gene Therapy (CGT) Logistic Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 103. NMDP BioTherapies Main Business
Table 104. NMDP BioTherapies Latest Developments
Table 105. McKesson Details, Company Type, Cell and Gene Therapy (CGT) Logistic Area Served and Its Competitors
Table 106. McKesson Cell and Gene Therapy (CGT) Logistic Product Offered
Table 107. McKesson Cell and Gene Therapy (CGT) Logistic Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 108. McKesson Main Business
Table 109. McKesson Latest Developments
Table 110. Excel Courier Details, Company Type, Cell and Gene Therapy (CGT) Logistic Area Served and Its Competitors
Table 111. Excel Courier Cell and Gene Therapy (CGT) Logistic Product Offered
Table 112. Excel Courier Cell and Gene Therapy (CGT) Logistic Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 113. Excel Courier Main Business
Table 114. Excel Courier Latest Developments
Table 115. Almac Details, Company Type, Cell and Gene Therapy (CGT) Logistic Area Served and Its Competitors
Table 116. Almac Cell and Gene Therapy (CGT) Logistic Product Offered
Table 117. Almac Cell and Gene Therapy (CGT) Logistic Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 118. Almac Main Business
Table 119. Almac Latest Developments
Table 120. BEAM Logistics Details, Company Type, Cell and Gene Therapy (CGT) Logistic Area Served and Its Competitors
Table 121. BEAM Logistics Cell and Gene Therapy (CGT) Logistic Product Offered
Table 122. BEAM Logistics Cell and Gene Therapy (CGT) Logistic Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 123. BEAM Logistics Main Business
Table 124. BEAM Logistics Latest Developments
Table 1. Cell and Gene Therapy (CGT) Logistic Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Cell and Gene Therapy (CGT) Logistic Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of National Transportation
Table 4. Major Players of International Transportation
Table 5. Cell and Gene Therapy (CGT) Logistic Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global Cell and Gene Therapy (CGT) Logistic Market Size by Type (2021-2026) & ($ millions)
Table 7. Global Cell and Gene Therapy (CGT) Logistic Market Size Market Share by Type (2021-2026)
Table 8. Cell and Gene Therapy (CGT) Logistic Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 9. Global Cell and Gene Therapy (CGT) Logistic Market Size by Application (2021-2026) & ($ millions)
Table 10. Global Cell and Gene Therapy (CGT) Logistic Market Size Market Share by Application (2021-2026)
Table 11. Global Cell and Gene Therapy (CGT) Logistic Revenue by Player (2021-2026) & ($ millions)
Table 12. Global Cell and Gene Therapy (CGT) Logistic Revenue Market Share by Player (2021-2026)
Table 13. Cell and Gene Therapy (CGT) Logistic Key Players Head office and Products Offered
Table 14. Cell and Gene Therapy (CGT) Logistic Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Cell and Gene Therapy (CGT) Logistic Market Size by Region (2021-2026) & ($ millions)
Table 18. Global Cell and Gene Therapy (CGT) Logistic Market Size Market Share by Region (2021-2026)
Table 19. Global Cell and Gene Therapy (CGT) Logistic Revenue by Country/Region (2021-2026) & ($ millions)
Table 20. Global Cell and Gene Therapy (CGT) Logistic Revenue Market Share by Country/Region (2021-2026)
Table 21. Americas Cell and Gene Therapy (CGT) Logistic Market Size by Country (2021-2026) & ($ millions)
Table 22. Americas Cell and Gene Therapy (CGT) Logistic Market Size Market Share by Country (2021-2026)
Table 23. Americas Cell and Gene Therapy (CGT) Logistic Market Size by Type (2021-2026) & ($ millions)
Table 24. Americas Cell and Gene Therapy (CGT) Logistic Market Size Market Share by Type (2021-2026)
Table 25. Americas Cell and Gene Therapy (CGT) Logistic Market Size by Application (2021-2026) & ($ millions)
Table 26. Americas Cell and Gene Therapy (CGT) Logistic Market Size Market Share by Application (2021-2026)
Table 27. APAC Cell and Gene Therapy (CGT) Logistic Market Size by Region (2021-2026) & ($ millions)
Table 28. APAC Cell and Gene Therapy (CGT) Logistic Market Size Market Share by Region (2021-2026)
Table 29. APAC Cell and Gene Therapy (CGT) Logistic Market Size by Type (2021-2026) & ($ millions)
Table 30. APAC Cell and Gene Therapy (CGT) Logistic Market Size by Application (2021-2026) & ($ millions)
Table 31. Europe Cell and Gene Therapy (CGT) Logistic Market Size by Country (2021-2026) & ($ millions)
Table 32. Europe Cell and Gene Therapy (CGT) Logistic Market Size Market Share by Country (2021-2026)
Table 33. Europe Cell and Gene Therapy (CGT) Logistic Market Size by Type (2021-2026) & ($ millions)
Table 34. Europe Cell and Gene Therapy (CGT) Logistic Market Size by Application (2021-2026) & ($ millions)
Table 35. Middle East & Africa Cell and Gene Therapy (CGT) Logistic Market Size by Region (2021-2026) & ($ millions)
Table 36. Middle East & Africa Cell and Gene Therapy (CGT) Logistic Market Size by Type (2021-2026) & ($ millions)
Table 37. Middle East & Africa Cell and Gene Therapy (CGT) Logistic Market Size by Application (2021-2026) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Cell and Gene Therapy (CGT) Logistic
Table 39. Key Market Challenges & Risks of Cell and Gene Therapy (CGT) Logistic
Table 40. Key Industry Trends of Cell and Gene Therapy (CGT) Logistic
Table 41. Global Cell and Gene Therapy (CGT) Logistic Market Size Forecast by Region (2027-2032) & ($ millions)
Table 42. Global Cell and Gene Therapy (CGT) Logistic Market Size Market Share Forecast by Region (2027-2032)
Table 43. Global Cell and Gene Therapy (CGT) Logistic Market Size Forecast by Type (2027-2032) & ($ millions)
Table 44. Global Cell and Gene Therapy (CGT) Logistic Market Size Forecast by Application (2027-2032) & ($ millions)
Table 45. Cencora, Inc?World Courier? Details, Company Type, Cell and Gene Therapy (CGT) Logistic Area Served and Its Competitors
Table 46. Cencora, Inc?World Courier? Cell and Gene Therapy (CGT) Logistic Product Offered
Table 47. Cencora, Inc?World Courier? Cell and Gene Therapy (CGT) Logistic Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 48. Cencora, Inc?World Courier? Main Business
Table 49. Cencora, Inc?World Courier? Latest Developments
Table 50. QuickStat Details, Company Type, Cell and Gene Therapy (CGT) Logistic Area Served and Its Competitors
Table 51. QuickStat Cell and Gene Therapy (CGT) Logistic Product Offered
Table 52. QuickStat Cell and Gene Therapy (CGT) Logistic Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 53. QuickStat Main Business
Table 54. QuickStat Latest Developments
Table 55. Associated Couriers, LLC Details, Company Type, Cell and Gene Therapy (CGT) Logistic Area Served and Its Competitors
Table 56. Associated Couriers, LLC Cell and Gene Therapy (CGT) Logistic Product Offered
Table 57. Associated Couriers, LLC Cell and Gene Therapy (CGT) Logistic Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 58. Associated Couriers, LLC Main Business
Table 59. Associated Couriers, LLC Latest Developments
Table 60. Central Pharma Details, Company Type, Cell and Gene Therapy (CGT) Logistic Area Served and Its Competitors
Table 61. Central Pharma Cell and Gene Therapy (CGT) Logistic Product Offered
Table 62. Central Pharma Cell and Gene Therapy (CGT) Logistic Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 63. Central Pharma Main Business
Table 64. Central Pharma Latest Developments
Table 65. POLAR EXPRES Details, Company Type, Cell and Gene Therapy (CGT) Logistic Area Served and Its Competitors
Table 66. POLAR EXPRES Cell and Gene Therapy (CGT) Logistic Product Offered
Table 67. POLAR EXPRES Cell and Gene Therapy (CGT) Logistic Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 68. POLAR EXPRES Main Business
Table 69. POLAR EXPRES Latest Developments
Table 70. Biocair Details, Company Type, Cell and Gene Therapy (CGT) Logistic Area Served and Its Competitors
Table 71. Biocair Cell and Gene Therapy (CGT) Logistic Product Offered
Table 72. Biocair Cell and Gene Therapy (CGT) Logistic Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 73. Biocair Main Business
Table 74. Biocair Latest Developments
Table 75. time:matters Details, Company Type, Cell and Gene Therapy (CGT) Logistic Area Served and Its Competitors
Table 76. time:matters Cell and Gene Therapy (CGT) Logistic Product Offered
Table 77. time:matters Cell and Gene Therapy (CGT) Logistic Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 78. time:matters Main Business
Table 79. time:matters Latest Developments
Table 80. Mercury Business Services Details, Company Type, Cell and Gene Therapy (CGT) Logistic Area Served and Its Competitors
Table 81. Mercury Business Services Cell and Gene Therapy (CGT) Logistic Product Offered
Table 82. Mercury Business Services Cell and Gene Therapy (CGT) Logistic Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 83. Mercury Business Services Main Business
Table 84. Mercury Business Services Latest Developments
Table 85. Cardinal Health Details, Company Type, Cell and Gene Therapy (CGT) Logistic Area Served and Its Competitors
Table 86. Cardinal Health Cell and Gene Therapy (CGT) Logistic Product Offered
Table 87. Cardinal Health Cell and Gene Therapy (CGT) Logistic Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 88. Cardinal Health Main Business
Table 89. Cardinal Health Latest Developments
Table 90. CRYOPDP Details, Company Type, Cell and Gene Therapy (CGT) Logistic Area Served and Its Competitors
Table 91. CRYOPDP Cell and Gene Therapy (CGT) Logistic Product Offered
Table 92. CRYOPDP Cell and Gene Therapy (CGT) Logistic Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 93. CRYOPDP Main Business
Table 94. CRYOPDP Latest Developments
Table 95. Cryoport Details, Company Type, Cell and Gene Therapy (CGT) Logistic Area Served and Its Competitors
Table 96. Cryoport Cell and Gene Therapy (CGT) Logistic Product Offered
Table 97. Cryoport Cell and Gene Therapy (CGT) Logistic Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 98. Cryoport Main Business
Table 99. Cryoport Latest Developments
Table 100. NMDP BioTherapies Details, Company Type, Cell and Gene Therapy (CGT) Logistic Area Served and Its Competitors
Table 101. NMDP BioTherapies Cell and Gene Therapy (CGT) Logistic Product Offered
Table 102. NMDP BioTherapies Cell and Gene Therapy (CGT) Logistic Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 103. NMDP BioTherapies Main Business
Table 104. NMDP BioTherapies Latest Developments
Table 105. McKesson Details, Company Type, Cell and Gene Therapy (CGT) Logistic Area Served and Its Competitors
Table 106. McKesson Cell and Gene Therapy (CGT) Logistic Product Offered
Table 107. McKesson Cell and Gene Therapy (CGT) Logistic Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 108. McKesson Main Business
Table 109. McKesson Latest Developments
Table 110. Excel Courier Details, Company Type, Cell and Gene Therapy (CGT) Logistic Area Served and Its Competitors
Table 111. Excel Courier Cell and Gene Therapy (CGT) Logistic Product Offered
Table 112. Excel Courier Cell and Gene Therapy (CGT) Logistic Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 113. Excel Courier Main Business
Table 114. Excel Courier Latest Developments
Table 115. Almac Details, Company Type, Cell and Gene Therapy (CGT) Logistic Area Served and Its Competitors
Table 116. Almac Cell and Gene Therapy (CGT) Logistic Product Offered
Table 117. Almac Cell and Gene Therapy (CGT) Logistic Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 118. Almac Main Business
Table 119. Almac Latest Developments
Table 120. BEAM Logistics Details, Company Type, Cell and Gene Therapy (CGT) Logistic Area Served and Its Competitors
Table 121. BEAM Logistics Cell and Gene Therapy (CGT) Logistic Product Offered
Table 122. BEAM Logistics Cell and Gene Therapy (CGT) Logistic Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 123. BEAM Logistics Main Business
Table 124. BEAM Logistics Latest Developments
LIST OF FIGURES
Figure 1. Cell and Gene Therapy (CGT) Logistic Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Cell and Gene Therapy (CGT) Logistic Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Cell and Gene Therapy (CGT) Logistic Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Cell and Gene Therapy (CGT) Logistic Sales Market Share by Country/Region (2025)
Figure 8. Cell and Gene Therapy (CGT) Logistic Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Cell and Gene Therapy (CGT) Logistic Market Size Market Share by Type in 2025
Figure 10. Cell and Gene Therapy (CGT) Logistic in Biotech and Pharmaceutical Companies
Figure 11. Global Cell and Gene Therapy (CGT) Logistic Market: Biotech and Pharmaceutical Companies (2021-2026) & ($ millions)
Figure 12. Cell and Gene Therapy (CGT) Logistic in Hospitals
Figure 13. Global Cell and Gene Therapy (CGT) Logistic Market: Hospitals (2021-2026) & ($ millions)
Figure 14. Cell and Gene Therapy (CGT) Logistic in Research Organizations
Figure 15. Global Cell and Gene Therapy (CGT) Logistic Market: Research Organizations (2021-2026) & ($ millions)
Figure 16. Cell and Gene Therapy (CGT) Logistic in Other
Figure 17. Global Cell and Gene Therapy (CGT) Logistic Market: Other (2021-2026) & ($ millions)
Figure 18. Global Cell and Gene Therapy (CGT) Logistic Market Size Market Share by Application in 2025
Figure 19. Global Cell and Gene Therapy (CGT) Logistic Revenue Market Share by Player in 2025
Figure 20. Global Cell and Gene Therapy (CGT) Logistic Market Size Market Share by Region (2021-2026)
Figure 21. Americas Cell and Gene Therapy (CGT) Logistic Market Size 2021-2026 ($ millions)
Figure 22. APAC Cell and Gene Therapy (CGT) Logistic Market Size 2021-2026 ($ millions)
Figure 23. Europe Cell and Gene Therapy (CGT) Logistic Market Size 2021-2026 ($ millions)
Figure 24. Middle East & Africa Cell and Gene Therapy (CGT) Logistic Market Size 2021-2026 ($ millions)
Figure 25. Americas Cell and Gene Therapy (CGT) Logistic Value Market Share by Country in 2025
Figure 26. United States Cell and Gene Therapy (CGT) Logistic Market Size Growth 2021-2026 ($ millions)
Figure 27. Canada Cell and Gene Therapy (CGT) Logistic Market Size Growth 2021-2026 ($ millions)
Figure 28. Mexico Cell and Gene Therapy (CGT) Logistic Market Size Growth 2021-2026 ($ millions)
Figure 29. Brazil Cell and Gene Therapy (CGT) Logistic Market Size Growth 2021-2026 ($ millions)
Figure 30. APAC Cell and Gene Therapy (CGT) Logistic Market Size Market Share by Region in 2025
Figure 31. APAC Cell and Gene Therapy (CGT) Logistic Market Size Market Share by Type (2021-2026)
Figure 32. APAC Cell and Gene Therapy (CGT) Logistic Market Size Market Share by Application (2021-2026)
Figure 33. China Cell and Gene Therapy (CGT) Logistic Market Size Growth 2021-2026 ($ millions)
Figure 34. Japan Cell and Gene Therapy (CGT) Logistic Market Size Growth 2021-2026 ($ millions)
Figure 35. South Korea Cell and Gene Therapy (CGT) Logistic Market Size Growth 2021-2026 ($ millions)
Figure 36. Southeast Asia Cell and Gene Therapy (CGT) Logistic Market Size Growth 2021-2026 ($ millions)
Figure 37. India Cell and Gene Therapy (CGT) Logistic Market Size Growth 2021-2026 ($ millions)
Figure 38. Australia Cell and Gene Therapy (CGT) Logistic Market Size Growth 2021-2026 ($ millions)
Figure 39. Europe Cell and Gene Therapy (CGT) Logistic Market Size Market Share by Country in 2025
Figure 40. Europe Cell and Gene Therapy (CGT) Logistic Market Size Market Share by Type (2021-2026)
Figure 41. Europe Cell and Gene Therapy (CGT) Logistic Market Size Market Share by Application (2021-2026)
Figure 42. Germany Cell and Gene Therapy (CGT) Logistic Market Size Growth 2021-2026 ($ millions)
Figure 43. France Cell and Gene Therapy (CGT) Logistic Market Size Growth 2021-2026 ($ millions)
Figure 44. UK Cell and Gene Therapy (CGT) Logistic Market Size Growth 2021-2026 ($ millions)
Figure 45. Italy Cell and Gene Therapy (CGT) Logistic Market Size Growth 2021-2026 ($ millions)
Figure 46. Russia Cell and Gene Therapy (CGT) Logistic Market Size Growth 2021-2026 ($ millions)
Figure 47. Middle East & Africa Cell and Gene Therapy (CGT) Logistic Market Size Market Share by Region (2021-2026)
Figure 48. Middle East & Africa Cell and Gene Therapy (CGT) Logistic Market Size Market Share by Type (2021-2026)
Figure 49. Middle East & Africa Cell and Gene Therapy (CGT) Logistic Market Size Market Share by Application (2021-2026)
Figure 50. Egypt Cell and Gene Therapy (CGT) Logistic Market Size Growth 2021-2026 ($ millions)
Figure 51. South Africa Cell and Gene Therapy (CGT) Logistic Market Size Growth 2021-2026 ($ millions)
Figure 52. Israel Cell and Gene Therapy (CGT) Logistic Market Size Growth 2021-2026 ($ millions)
Figure 53. Turkey Cell and Gene Therapy (CGT) Logistic Market Size Growth 2021-2026 ($ millions)
Figure 54. GCC Countries Cell and Gene Therapy (CGT) Logistic Market Size Growth 2021-2026 ($ millions)
Figure 55. Americas Cell and Gene Therapy (CGT) Logistic Market Size 2027-2032 ($ millions)
Figure 56. APAC Cell and Gene Therapy (CGT) Logistic Market Size 2027-2032 ($ millions)
Figure 57. Europe Cell and Gene Therapy (CGT) Logistic Market Size 2027-2032 ($ millions)
Figure 58. Middle East & Africa Cell and Gene Therapy (CGT) Logistic Market Size 2027-2032 ($ millions)
Figure 59. United States Cell and Gene Therapy (CGT) Logistic Market Size 2027-2032 ($ millions)
Figure 60. Canada Cell and Gene Therapy (CGT) Logistic Market Size 2027-2032 ($ millions)
Figure 61. Mexico Cell and Gene Therapy (CGT) Logistic Market Size 2027-2032 ($ millions)
Figure 62. Brazil Cell and Gene Therapy (CGT) Logistic Market Size 2027-2032 ($ millions)
Figure 63. China Cell and Gene Therapy (CGT) Logistic Market Size 2027-2032 ($ millions)
Figure 64. Japan Cell and Gene Therapy (CGT) Logistic Market Size 2027-2032 ($ millions)
Figure 65. Korea Cell and Gene Therapy (CGT) Logistic Market Size 2027-2032 ($ millions)
Figure 66. Southeast Asia Cell and Gene Therapy (CGT) Logistic Market Size 2027-2032 ($ millions)
Figure 67. India Cell and Gene Therapy (CGT) Logistic Market Size 2027-2032 ($ millions)
Figure 68. Australia Cell and Gene Therapy (CGT) Logistic Market Size 2027-2032 ($ millions)
Figure 69. Germany Cell and Gene Therapy (CGT) Logistic Market Size 2027-2032 ($ millions)
Figure 70. France Cell and Gene Therapy (CGT) Logistic Market Size 2027-2032 ($ millions)
Figure 71. UK Cell and Gene Therapy (CGT) Logistic Market Size 2027-2032 ($ millions)
Figure 72. Italy Cell and Gene Therapy (CGT) Logistic Market Size 2027-2032 ($ millions)
Figure 73. Russia Cell and Gene Therapy (CGT) Logistic Market Size 2027-2032 ($ millions)
Figure 74. Egypt Cell and Gene Therapy (CGT) Logistic Market Size 2027-2032 ($ millions)
Figure 75. South Africa Cell and Gene Therapy (CGT) Logistic Market Size 2027-2032 ($ millions)
Figure 76. Israel Cell and Gene Therapy (CGT) Logistic Market Size 2027-2032 ($ millions)
Figure 77. Turkey Cell and Gene Therapy (CGT) Logistic Market Size 2027-2032 ($ millions)
Figure 78. Global Cell and Gene Therapy (CGT) Logistic Market Size Market Share Forecast by Type (2027-2032)
Figure 79. Global Cell and Gene Therapy (CGT) Logistic Market Size Market Share Forecast by Application (2027-2032)
Figure 80. GCC Countries Cell and Gene Therapy (CGT) Logistic Market Size 2027-2032 ($ millions)
Figure 1. Cell and Gene Therapy (CGT) Logistic Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Cell and Gene Therapy (CGT) Logistic Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Cell and Gene Therapy (CGT) Logistic Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Cell and Gene Therapy (CGT) Logistic Sales Market Share by Country/Region (2025)
Figure 8. Cell and Gene Therapy (CGT) Logistic Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Cell and Gene Therapy (CGT) Logistic Market Size Market Share by Type in 2025
Figure 10. Cell and Gene Therapy (CGT) Logistic in Biotech and Pharmaceutical Companies
Figure 11. Global Cell and Gene Therapy (CGT) Logistic Market: Biotech and Pharmaceutical Companies (2021-2026) & ($ millions)
Figure 12. Cell and Gene Therapy (CGT) Logistic in Hospitals
Figure 13. Global Cell and Gene Therapy (CGT) Logistic Market: Hospitals (2021-2026) & ($ millions)
Figure 14. Cell and Gene Therapy (CGT) Logistic in Research Organizations
Figure 15. Global Cell and Gene Therapy (CGT) Logistic Market: Research Organizations (2021-2026) & ($ millions)
Figure 16. Cell and Gene Therapy (CGT) Logistic in Other
Figure 17. Global Cell and Gene Therapy (CGT) Logistic Market: Other (2021-2026) & ($ millions)
Figure 18. Global Cell and Gene Therapy (CGT) Logistic Market Size Market Share by Application in 2025
Figure 19. Global Cell and Gene Therapy (CGT) Logistic Revenue Market Share by Player in 2025
Figure 20. Global Cell and Gene Therapy (CGT) Logistic Market Size Market Share by Region (2021-2026)
Figure 21. Americas Cell and Gene Therapy (CGT) Logistic Market Size 2021-2026 ($ millions)
Figure 22. APAC Cell and Gene Therapy (CGT) Logistic Market Size 2021-2026 ($ millions)
Figure 23. Europe Cell and Gene Therapy (CGT) Logistic Market Size 2021-2026 ($ millions)
Figure 24. Middle East & Africa Cell and Gene Therapy (CGT) Logistic Market Size 2021-2026 ($ millions)
Figure 25. Americas Cell and Gene Therapy (CGT) Logistic Value Market Share by Country in 2025
Figure 26. United States Cell and Gene Therapy (CGT) Logistic Market Size Growth 2021-2026 ($ millions)
Figure 27. Canada Cell and Gene Therapy (CGT) Logistic Market Size Growth 2021-2026 ($ millions)
Figure 28. Mexico Cell and Gene Therapy (CGT) Logistic Market Size Growth 2021-2026 ($ millions)
Figure 29. Brazil Cell and Gene Therapy (CGT) Logistic Market Size Growth 2021-2026 ($ millions)
Figure 30. APAC Cell and Gene Therapy (CGT) Logistic Market Size Market Share by Region in 2025
Figure 31. APAC Cell and Gene Therapy (CGT) Logistic Market Size Market Share by Type (2021-2026)
Figure 32. APAC Cell and Gene Therapy (CGT) Logistic Market Size Market Share by Application (2021-2026)
Figure 33. China Cell and Gene Therapy (CGT) Logistic Market Size Growth 2021-2026 ($ millions)
Figure 34. Japan Cell and Gene Therapy (CGT) Logistic Market Size Growth 2021-2026 ($ millions)
Figure 35. South Korea Cell and Gene Therapy (CGT) Logistic Market Size Growth 2021-2026 ($ millions)
Figure 36. Southeast Asia Cell and Gene Therapy (CGT) Logistic Market Size Growth 2021-2026 ($ millions)
Figure 37. India Cell and Gene Therapy (CGT) Logistic Market Size Growth 2021-2026 ($ millions)
Figure 38. Australia Cell and Gene Therapy (CGT) Logistic Market Size Growth 2021-2026 ($ millions)
Figure 39. Europe Cell and Gene Therapy (CGT) Logistic Market Size Market Share by Country in 2025
Figure 40. Europe Cell and Gene Therapy (CGT) Logistic Market Size Market Share by Type (2021-2026)
Figure 41. Europe Cell and Gene Therapy (CGT) Logistic Market Size Market Share by Application (2021-2026)
Figure 42. Germany Cell and Gene Therapy (CGT) Logistic Market Size Growth 2021-2026 ($ millions)
Figure 43. France Cell and Gene Therapy (CGT) Logistic Market Size Growth 2021-2026 ($ millions)
Figure 44. UK Cell and Gene Therapy (CGT) Logistic Market Size Growth 2021-2026 ($ millions)
Figure 45. Italy Cell and Gene Therapy (CGT) Logistic Market Size Growth 2021-2026 ($ millions)
Figure 46. Russia Cell and Gene Therapy (CGT) Logistic Market Size Growth 2021-2026 ($ millions)
Figure 47. Middle East & Africa Cell and Gene Therapy (CGT) Logistic Market Size Market Share by Region (2021-2026)
Figure 48. Middle East & Africa Cell and Gene Therapy (CGT) Logistic Market Size Market Share by Type (2021-2026)
Figure 49. Middle East & Africa Cell and Gene Therapy (CGT) Logistic Market Size Market Share by Application (2021-2026)
Figure 50. Egypt Cell and Gene Therapy (CGT) Logistic Market Size Growth 2021-2026 ($ millions)
Figure 51. South Africa Cell and Gene Therapy (CGT) Logistic Market Size Growth 2021-2026 ($ millions)
Figure 52. Israel Cell and Gene Therapy (CGT) Logistic Market Size Growth 2021-2026 ($ millions)
Figure 53. Turkey Cell and Gene Therapy (CGT) Logistic Market Size Growth 2021-2026 ($ millions)
Figure 54. GCC Countries Cell and Gene Therapy (CGT) Logistic Market Size Growth 2021-2026 ($ millions)
Figure 55. Americas Cell and Gene Therapy (CGT) Logistic Market Size 2027-2032 ($ millions)
Figure 56. APAC Cell and Gene Therapy (CGT) Logistic Market Size 2027-2032 ($ millions)
Figure 57. Europe Cell and Gene Therapy (CGT) Logistic Market Size 2027-2032 ($ millions)
Figure 58. Middle East & Africa Cell and Gene Therapy (CGT) Logistic Market Size 2027-2032 ($ millions)
Figure 59. United States Cell and Gene Therapy (CGT) Logistic Market Size 2027-2032 ($ millions)
Figure 60. Canada Cell and Gene Therapy (CGT) Logistic Market Size 2027-2032 ($ millions)
Figure 61. Mexico Cell and Gene Therapy (CGT) Logistic Market Size 2027-2032 ($ millions)
Figure 62. Brazil Cell and Gene Therapy (CGT) Logistic Market Size 2027-2032 ($ millions)
Figure 63. China Cell and Gene Therapy (CGT) Logistic Market Size 2027-2032 ($ millions)
Figure 64. Japan Cell and Gene Therapy (CGT) Logistic Market Size 2027-2032 ($ millions)
Figure 65. Korea Cell and Gene Therapy (CGT) Logistic Market Size 2027-2032 ($ millions)
Figure 66. Southeast Asia Cell and Gene Therapy (CGT) Logistic Market Size 2027-2032 ($ millions)
Figure 67. India Cell and Gene Therapy (CGT) Logistic Market Size 2027-2032 ($ millions)
Figure 68. Australia Cell and Gene Therapy (CGT) Logistic Market Size 2027-2032 ($ millions)
Figure 69. Germany Cell and Gene Therapy (CGT) Logistic Market Size 2027-2032 ($ millions)
Figure 70. France Cell and Gene Therapy (CGT) Logistic Market Size 2027-2032 ($ millions)
Figure 71. UK Cell and Gene Therapy (CGT) Logistic Market Size 2027-2032 ($ millions)
Figure 72. Italy Cell and Gene Therapy (CGT) Logistic Market Size 2027-2032 ($ millions)
Figure 73. Russia Cell and Gene Therapy (CGT) Logistic Market Size 2027-2032 ($ millions)
Figure 74. Egypt Cell and Gene Therapy (CGT) Logistic Market Size 2027-2032 ($ millions)
Figure 75. South Africa Cell and Gene Therapy (CGT) Logistic Market Size 2027-2032 ($ millions)
Figure 76. Israel Cell and Gene Therapy (CGT) Logistic Market Size 2027-2032 ($ millions)
Figure 77. Turkey Cell and Gene Therapy (CGT) Logistic Market Size 2027-2032 ($ millions)
Figure 78. Global Cell and Gene Therapy (CGT) Logistic Market Size Market Share Forecast by Type (2027-2032)
Figure 79. Global Cell and Gene Therapy (CGT) Logistic Market Size Market Share Forecast by Application (2027-2032)
Figure 80. GCC Countries Cell and Gene Therapy (CGT) Logistic Market Size 2027-2032 ($ millions)
